Simplified Chinese
CCTV’s Finance Channel provides an authoritative analysis: With the first Vaccine Administration Law now in effect, what improvements can we expect from domestically produced vaccines?
Release date:
2019-08-06
Author:
Source:
Abstract
Since the enactment of the Vaccine Administration Law, what impact will it have on China’s domestic vaccine industry? How are vaccine companies preparing to comply with this new legislation? Recently, Miao Xiang, Secretary of the Board at Kintor Pharmaceutical, and Zhu Zhengyu, Head of Quality, were interviewed by CCTV’s Finance Channel. They outlined the company’s active participation in drafting the law, as well as its concrete measures to continuously enhance quality‑control standards and advance the development of innovative vaccine products. The program aired on July 31 at 2:00 p.m.

Recommended Reading
Batch Release Status of the Company’s Products in 2026
2026-07-23
2026-07-15
2026-07-09